CF PharmTech

CF PharmTech EBITDA per Share

The EBITDA per Share of CF PharmTech (2652.HK) as of Oct 11, 2026 is -0.02 CNY. In the previous year, EBITDA per Share was 0.05 CNY — a change of -132.74% (lower).

EBITDA per Share

-0.02CNY

YoY

-132.74%

Last updated:

EBITDA per Share of CF PharmTech is 2025 -0.02 CNY. EBITDA per Share of CF PharmTech was 2024 0.05 CNY. It decreases by -132.74% lower compared to the previous year.

The CF PharmTech EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2022
-0.17 CNY
Jan 1, 2023
0.06 CNY
Jan 1, 2024
0.05 CNY
Jan 1, 2025
-0.02 CNY
The CF PharmTech EBITDA per Share history
YEAREBITDA per ShareYoY
-0.02CNY-132.74%
0.05CNY-7.34%
0.06CNY-132.23%
-0.17CNY—
Access this data via the Eulerpool API
Get Free API Key

CF PharmTech Stock analysis

What does CF PharmTech do? CF PharmTech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CF PharmTech stock

EBITDA per Share of CF PharmTech is -0.02 CNY in 2025.

EBITDA per Share of CF PharmTech changed from 0.05 CNY to -0.02 CNY, representing a -132.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share CF PharmTech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — CF PharmTech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — CF PharmTech